Cellid Co Ltd (299660)

Currency in KRW
2,590
+205(+8.60%)
Closed·
Advertisement
299660 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,5052,900
52 wk Range
9734,760
Key Statistics
Bid/Ask
2,610.00 / 2,615.00
Prev. Close
2,385
Open
2,510
Day's Range
2,505-2,900
52 wk Range
973-4,760
Volume
5.77M
Average Volume (3m)
1.97M
1-Year Change
-30.9333%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
299660 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Earnings

Latest Release
01/03/2025
EPS / Forecast
-169.42 / --
Revenue / Forecast
1.88B / --
EPS Revisions
Last 90 days

Compare 299660 to Peers and Sector

Metrics to compare
299660
Peers
Sector
Relationship
P/E Ratio
0.0x−4.6x−0.3x
PEG Ratio
0.000.280.00
Price/Book
0.0x1.9x2.6x
Price / LTM Sales
0.0x8.5x3.0x
Upside (Analyst Target)
0.0%39.9%58.2%
Fair Value Upside
Unlock15.7%7.5%Unlock

Cellid, Co., Ltd. develops immunotherapeutic vaccines for cancer and/or infectious diseases therapies. It is developing BVAC-C for cervical, head and neck, anal, and sex organ cancer with human papilloma virus infection; BVAC-B for stomach, breast, and ovarian cancer with HER-2/neu antigen; and BVAC-P for prostate cancer, renal cell cancer, and glioblastoma with prostate acid phosphatase (PAP) and prostate-specific membrane (PSMA) antigens. The company is also developing BVAC-M for cancers, such as melanoma with GP100/MAGE-A3 antigens; BVAC-Neo. Cellid, Co., Ltd. was founded in 2006 and is headquartered in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
300.000.00%733.50K
Public Companies & Retail Investors
29.41M100.00%71.91B
Total
29.41M100.00%71.91B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Cellid, Inc., Employee Stock Ownership Association0.00%300734

People Also Watch

11,420
002990
-3.38%
5,400
079650
-3.74%
3,205
228340
+0.16%
384
035290
0.00%

FAQ

What Is the Cellid (KOSDAQ: 299660) Share Price Today?

The Cellid stock price today is 2,590 KRW.

What Stock Exchange Does Cellid (299660) Trade On?

Cellid is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for Cellid?

The stock symbol (also called a 'ticker') for Cellid is "299660."

What Is the Current Cellid Market Capitalisation?

As of today, Cellid (KOSDAQ: 299660) market cap is 70.36B KRW.

Is 299660 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Cellid moving averages and other technical indicators, the daily buy/sell signal for 299660 stock is Neutral.

How Many Times Has Cellid Stock Split?

Cellid has split 0 times. (See the 299660 stock split history page for full effective split date and price information.)

What is the current trading status of Cellid (KOSDAQ: 299660)?

As of 07/10/2026, Cellid (299660) is trading at a share price of 2,590 KRW, with a previous close of 2,385 KRW. The stock has fluctuated within a day range of 2,505 KRW to 2,900 KRW, while its 52-week range spans from 973 KRW to 4,760 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.